Comparison of prognostic values between combined immunohistochemical score of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67 and the corresponding gene expression score in breast cancer

Growth Factor ◽

Growth Factor Receptor ◽

Ki 67 ◽

Epidermal Growth ◽

Expression Score ◽

Gene Expression Score

Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

Yearbook of Pathology and Laboratory Medicine ◽

10.1016/j.ypat.2011.11.065 ◽

2012 ◽

Vol 2012 ◽

pp. 20-21

Author(s):

B.A. Carter

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Prognostic Value ◽

Growth Factor Receptor ◽

Recurrence Score ◽

Ki 67 ◽

Effect of neoadjuvant chemotherapy on expressions of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in breast cancer

Chinese Medical Journal ◽

10.1097/00029330-201409200-00015 ◽

2014 ◽

Vol 127 (18) ◽

pp. 3272-3277 ◽

Cited By ~ 5

Author(s):

Qin Qinghong ◽

Gao Fangfang ◽

Jiang Wei ◽

Tan Qixing ◽

Mo Qinguo ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Neoadjuvant Chemotherapy ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Ki 67 ◽

Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Testing in Breast Cancer

Applied Immunohistochemistry & Molecular Morphology ◽

10.1097/pai.0000000000000525 ◽

2019 ◽

Vol 27 (1) ◽

pp. 1-7 ◽

Cited By ~ 1

Author(s):

Nosaibah Hariri ◽

Farnaz Hasteh ◽

Vighnesh Walavalkar ◽

Andres A. Roma ◽

Oluwole Fadare

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer

International Journal of General Medicine ◽

10.2147/ijgm.s314055 ◽

2021 ◽

Vol Volume 14 ◽

pp. 2777-2783

Author(s):

Gulijire Tailaiti ◽

Gulanbaier Maimaiti ◽

Youlituzi Aikeremu ◽

Batuer Tuerdi

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Invasive Breast Cancer ◽

Growth Factor Receptor ◽

X Ray ◽

Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells

Molecular Medicine Reports ◽

10.3892/mmr.2018.8580 ◽

2018 ◽

Cited By ~ 1

Author(s):

Seung Taek Lim ◽

Ye Won Jeon ◽

Hongki Gwak ◽

Se Young Kim ◽

Young Jin Suh

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Breast Cancer Cells ◽

Growth Factor Receptor ◽

Anticancer Effects ◽

Estrogen Receptor Positive ◽

Epidermal Growth ◽

Positive Breast Cancer

Evaluation of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Status Before and After Neoadjuvant Chemotherapy in Breast Cancer Patients

Indian Journal of Surgery ◽

10.1007/s12262-020-02380-y ◽

2020 ◽

Author(s):

Adarsh Verma ◽

Amrita Ghosh Kar ◽

Ram Niwas Meena ◽

S. C. U. Patne ◽

Shashi Prakash Mishra ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Neoadjuvant Chemotherapy ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Before And After ◽

Correlation between microRNA-21, microRNA-206 and estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 in breast cancer

Clinical Biochemistry ◽

10.1016/j.clinbiochem.2019.07.002 ◽

2019 ◽

Vol 71 ◽

pp. 52-57 ◽

Cited By ~ 4

Author(s):

Yuanwen Chen ◽

Nian Wu ◽

Lei Liu ◽

Huaying Dong ◽

Chengyi Wu

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Abstract P3-01-04: DETECT V – Expression analysis of human epidermal growth factor receptor 2 and estrogen receptor on circulating tumor cells of metastatic breast cancer patients

10.1158/1538-7445.sabcs18-p3-01-04 ◽

2019 ◽

Author(s):

T Fehm ◽

F Meier-Stiegen ◽

S Riethdorf ◽

B Rack ◽

F-A Taran ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Abstract OT1-03-01: Phase 1/1b study of novel oral selective estrogen receptor degrader (SERD) LSZ102 in combination with alpelisib (BYL719) in estrogen receptor-positive (ER+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) with progression on endocrine therapy (ET)

10.1158/1538-7445.sabcs18-ot1-03-01 ◽

2019 ◽

Author(s):

G Curigliano ◽

S Cresta ◽

Y-S Yap ◽

D Juric ◽

FP Duhoux ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Advanced Breast Cancer ◽

Phase 1 ◽

Growth Factor Receptor ◽

Estrogen Receptor Positive ◽

Abstract PD7-07: Final analysis of phase 1 study of elacestrant (RAD1901), a novel selective estrogen receptor degrader (SERD), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer

10.1158/1538-7445.sabcs19-pd7-07 ◽

2020 ◽

Author(s):

Virginia Kaklamani ◽

Aditya Bardia ◽

Sharon Wilks ◽

Amy Weise ◽

Donald Richards ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Phase 1 ◽

Growth Factor Receptor ◽

Final Analysis ◽

Phase 1 Study ◽

Estrogen Receptor Positive ◽